Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The glutamate-gated chloride ion channel alpha-type subunit, encoded by the Avr-14 gene, is a member of the ligand-gated ion channel superfamily found in invertebrates. This protein forms part of a pentameric receptor complex that mediates inhibitory neurotransmission by allowing chloride ions to flow across cell membranes upon activation by extracellular glutamate. It is a primary target for macrocyclic lactone drugs such as ivermectin, and mutations in Avr-14 can confer resistance to these drugs.
Allosteric modulation leading to persistent channel opening and chloride influx, causing hyperpolarization and paralysis.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutamate-gated chloride ion channel alpha-type subunit (GluClα).